檢索結果 - Vivek Yanamadala

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development

    Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development 由 Juan Gu, Anil Singh, Kai Xue, Cory Mavis, Matthew J. Barth, Vivek Yanamadala, Peter Lenz, Michael Grau, Georg Lenz, Myron S. Czuczman, Francisco J. Hernandez‐Ilizaliturri

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: